NEFL and myeloid sarcoma: Elevated NfL levels have been associated with faster disease progression or reduced survival in conditions such as ALS [46,47], Parkinson’s disease (PD) [48], MS [49], frontotemporal lobar degeneration (FTLD) [50], and stroke [18,21].